BTNL3 and cancer: While Vγ4–EPCR binding can be inhibited by the markedly higher binding affinity of Vγ4 to BTNL3, BTNL3 is significantly downregulated in colorectal cancer (CRC) whereas EPCR is commonly overexpressed in CRC and multiple other cancers [10–17].